Bin Yan
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Molecular Biology top 2%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 10
- RNA Interference and Gene Delivery 9
- Gut microbiota and health 7
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 8
- Cancer, Hypoxia, and Metabolism 8
- NF-κB Signaling Pathways 8
- Co-authors
- Yongguang Tao (15 shared papers)Chuan‐Yuan Li (6 shared papers)Ya Cao (12 shared papers)Qingyong Ma (14 shared papers)Liang Cheng (14 shared papers)Mark W. Dewhirst (5 shared papers)Yiqun Jiang (12 shared papers)Weikun Qian (13 shared papers)
- Journals
- Scientific Reports (5 papers)Cancer Research (4 papers)Oncology Reports (3 papers)Frontiers in Microbiology (3 papers)Cancers (3 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Bin Yan
166 papers receiving 5.2k citations
Bin Yan's Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 1.4k
- Molecular Biology 2.7k
- Geriatrics and Gerontology 121
- Oncology 821
- Immunology 655
Countries citing papers authored by Bin Yan
This map shows the geographic impact of Bin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Yan more than expected).
Fields of papers citing papers by Bin Yan
This network shows the impact of papers produced by Bin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Yan. The network helps show where Bin Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53 Hit paper breakdown → | 2018 | 415 |
| 2 | 2007 | 385 | |
| 3 | 2017 | 244 | |
| 4 | 2015 | 161 | |
| 5 | 2020 | 158 | |
| 6 | 2006 | 140 | |
| 7 | 2018 | 128 | |
| 8 | 2017 | 115 | |
| 9 | 2017 | 106 | |
| 10 | 2020 | 103 | |
| 11 | 2013 | 102 | |
| 12 | 2022 | 99 | |
| 13 | 2009 | 94 | |
| 14 | 2020 | 89 | |
| 15 | 2021 | 88 | |
| 16 | 2011 | 88 | |
| 17 | 2016 | 87 | |
| 18 | 2016 | 86 | |
| 19 | 2018 | 81 | |
| 20 | 2018 | 75 |
About Bin Yan
Bin Yan is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Surgery, having authored 178 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (10 papers), RNA Interference and Gene Delivery (9 papers), MicroRNA in disease regulation (8 papers), Cancer, Hypoxia, and Metabolism (8 papers), NF-κB Signaling Pathways (8 papers), Gut microbiota and health (7 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (2.7k citations), Geriatrics and Gerontology (121 citations), Oncology (821 citations) and Immunology (655 citations). Bin Yan has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Yongguang Tao, Chuan‐Yuan Li, Ya Cao, Qingyong Ma, Liang Cheng, Mark W. Dewhirst, Yiqun Jiang, Weikun Qian, Junyu Cao and Fang Li. Their work appears in journals such as Scientific Reports, Cancer Research, Oncology Reports, Frontiers in Microbiology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.